Growth at Reasonable Price
Results
5
1 new
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
KURN New | CHF 23.54 | 15.4% | -21.2% | CHF 808.1m | CHF 33.94 | 460.1 | 58.4% | n/a | Pharmaceuticals & Biotech | ||
NWRN | CHF 11.54 | -4.6% | 65.6% | CHF 250.5m | CHF 47.48 | 13.4 | 50.2% | n/a | Pharmaceuticals & Biotech | ||
LMN | CHF 13.80 | 4.9% | -14.8% | CHF 144.8m | CHF 19.16 | 13.5 | 20.5% | 2.8% | Consumer Services | ||
RIEN | CHF 3.04 | 7.0% | -95.1% | CHF 414.7m | CHF 3.40 | 0.4 | 102.7% | 0% | Capital Goods | ||
CICN | CHF 117.60 | -15.6% | -39.4% | CHF 534.2m | CHF 169.10 | 34.7 | 40.2% | 0% | Tech |
Page 1 of 1